Buntinx; Erik Patent Filings

Patent	Date
Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists Grant 8,304,431 - Buntinx November 6, 2	2012-11-06
Low Dose Pipamperone In Treating Mood Disorders App 20120010242 - Buntinx; Erik	2012-01-12
Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists App 20110207776 - Buntinx; Erik	2011-08-25
Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists App 20110172251 - Buntinx; Erik	2011-07-14
Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists App 20110136865 - Buntinx; Erik	2011-06-09
Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists Grant 7,884,096 - Buntinx February 8, 2	2011-02-08
Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists Grant 7,855,195 - Buntinx December 21, 2	2010-12-21
Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists App 20070078162 - Buntinx; Erik	2007-04-05
Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists App 20050203130 - Buntinx, Erik	2005-09-15
Method of treating neurodegenerative diseases using D4 and 5-HT2A antagonists, inverse agonists or partial agonists App 20050119249 - Buntinx, Erik	2005-06-02
Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists App 20050119248 - Buntinx, Erik	2005-06-02
Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists App 20050119253 - Buntinx, Erik	2005-06-02

Patent

Date

Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
Grant 8,304,431 - Buntinx November 6, 2

2012-11-06

Low Dose Pipamperone In Treating Mood Disorders
App 20120010242 - Buntinx; Erik

2012-01-12

Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
App 20110207776 - Buntinx; Erik

2011-08-25

Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
App 20110172251 - Buntinx; Erik

2011-07-14

Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
App 20110136865 - Buntinx; Erik

2011-06-09

Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
Grant 7,884,096 - Buntinx February 8, 2

2011-02-08

Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
Grant 7,855,195 - Buntinx December 21, 2

2010-12-21

Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
App 20070078162 - Buntinx; Erik

2007-04-05

Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
App 20050203130 - Buntinx, Erik

2005-09-15

Method of treating neurodegenerative diseases using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
App 20050119249 - Buntinx, Erik

2005-06-02

Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
App 20050119248 - Buntinx, Erik

2005-06-02

Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
App 20050119253 - Buntinx, Erik

2005-06-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

Buntinx; Erik

Patent Applications and Registrations